Global S-Amlodipine Market Growth 2026-2032

September 2026 | 124 pages | ID: GC92A2326051EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global S-Amlodipine market size is predicted to grow from US$ 47040 million in 2025 to US$ 100790 million in 2032; it is expected to grow at a CAGR of 11.7% from 2026 to 2032.

S AMLODIPINE belongs to a class of medicines called calcium channel blockers which are primarily taken to treat hypertension (high blood pressure) and angina (chest pain).

Hypertension is a common cardiovascular disease affecting a large proportion of the global population. The increasing prevalence of hypertension worldwide is driving the demand for effective antihypertensive drugs such as S-amlodipine.

LP Information, Inc. (LPI) ' newest research report, the “S-Amlodipine Industry Forecast” looks at past sales and reviews total world S-Amlodipine sales in 2025, providing a comprehensive analysis by region and market sector of projected S-Amlodipine sales for 2026 through 2032. With S-Amlodipine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world S-Amlodipine industry.

This Insight Report provides a comprehensive analysis of the global S-Amlodipine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on S-Amlodipine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global S-Amlodipine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for S-Amlodipine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global S-Amlodipine.

This report presents a comprehensive overview, market shares, and growth opportunities of S-Amlodipine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Amlodipine Besylate Tablets
  • Amlodipine Mesylate Tablets
  • Amlodipine Maleate Tablets
Segmentation by Application:
  • Hypertension
  • Angina pectoris
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Aristo Pharmaceuticals Pvt Ltd
  • Novartis
  • Pfizer
  • Lek
  • TEVA
  • Macleods Pharmaceuticals
  • Caraco Pharmaceutical
  • Sanis Health
  • Jamp Pharma
  • Accel Pharma
  • Jubilant Generics
  • Angita Pharma
  • Florida DOH Central Pharmacy
  • Chengdu Di'ao Pharmaceutical Group Co., Ltd.
  • Yangzijiang Pharmaceutical
Key Questions Addressed in this Report
  • What is the 10-year outlook for the global S-Amlodipine market?
  • What factors are driving S-Amlodipine market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do S-Amlodipine market opportunities vary by end market size?
  • How does S-Amlodipine break out by Type, by Application?
1 SCOPE OF THE REPORT

  1.1 Market Introduction
  1.2 Years Considered
  1.3 Research Objectives
  1.4 Market Research Methodology
  1.5 Research Process and Data Source
  1.6 Economic Indicators
  1.7 Currency Considered
  1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

  2.1 World Market Overview
  2.1.1 Global S-Amlodipine Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for S-Amlodipine by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for S-Amlodipine by Country/Region, 2021, 2025 & 2032
  2.2 S-Amlodipine Segment by Type
  2.2.1 Amlodipine Besylate Tablets
  2.2.2 Amlodipine Mesylate Tablets
  2.2.3 Amlodipine Maleate Tablets
  2.2.4 S-Amlodipine Sales by Type
  2.2.4.1 Global S-Amlodipine Sales Market Share by Type (2021-2026)
  2.2.4.2 Global S-Amlodipine Revenue and Market Share by Type (2021-2026)
  2.2.4.3 Global S-Amlodipine Sale Price by Type (2021-2026)
  2.3 S-Amlodipine Segment by Application
  2.3.1 Hypertension
  2.3.2 Angina pectoris
  2.3.3 S-Amlodipine Sales by Application
  2.3.3.1 Global S-Amlodipine Sale Market Share by Application (2021-2026)
  2.3.3.2 Global S-Amlodipine Revenue and Market Share by Application (2021-2026)
  2.3.3.3 Global S-Amlodipine Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

  3.1 Global S-Amlodipine Breakdown Data by Company
  3.1.1 Global S-Amlodipine Annual Sales by Company (2021-2026)
  3.1.2 Global S-Amlodipine Sales Market Share by Company (2021-2026)
  3.2 Global S-Amlodipine Annual Revenue by Company (2021-2026)
  3.2.1 Global S-Amlodipine Revenue by Company (2021-2026)
  3.2.2 Global S-Amlodipine Revenue Market Share by Company (2021-2026)
  3.3 Global S-Amlodipine Sale Price by Company
  3.4 Key Manufacturers S-Amlodipine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers S-Amlodipine Product Location Distribution
  3.4.2 Players S-Amlodipine Products Offered
  3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
  3.6 New Products and Potential Entrants
  3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR S-AMLODIPINE BY GEOGRAPHIC REGION

  4.1 World Historic S-Amlodipine Market Size by Geographic Region (2021-2026)
  4.1.1 Global S-Amlodipine Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global S-Amlodipine Annual Revenue by Geographic Region (2021-2026)
  4.2 World Historic S-Amlodipine Market Size by Country/Region (2021-2026)
  4.2.1 Global S-Amlodipine Annual Sales by Country/Region (2021-2026)
  4.2.2 Global S-Amlodipine Annual Revenue by Country/Region (2021-2026)
  4.3 Americas S-Amlodipine Sales Growth
  4.4 APAC S-Amlodipine Sales Growth
  4.5 Europe S-Amlodipine Sales Growth
  4.6 Middle East & Africa S-Amlodipine Sales Growth

5 AMERICAS

  5.1 Americas S-Amlodipine Sales by Country
  5.1.1 Americas S-Amlodipine Sales by Country (2021-2026)
  5.1.2 Americas S-Amlodipine Revenue by Country (2021-2026)
  5.2 Americas S-Amlodipine Sales by Type (2021-2026)
  5.3 Americas S-Amlodipine Sales by Application (2021-2026)
  5.4 United States
  5.5 Canada
  5.6 Mexico
  5.7 Brazil

6 APAC

  6.1 APAC S-Amlodipine Sales by Region
  6.1.1 APAC S-Amlodipine Sales by Region (2021-2026)
  6.1.2 APAC S-Amlodipine Revenue by Region (2021-2026)
  6.2 APAC S-Amlodipine Sales by Type (2021-2026)
  6.3 APAC S-Amlodipine Sales by Application (2021-2026)
  6.4 China
  6.5 Japan
  6.6 South Korea
  6.7 Southeast Asia
  6.8 India
  6.9 Australia
  6.10 China Taiwan

7 EUROPE

  7.1 Europe S-Amlodipine by Country
  7.1.1 Europe S-Amlodipine Sales by Country (2021-2026)
  7.1.2 Europe S-Amlodipine Revenue by Country (2021-2026)
  7.2 Europe S-Amlodipine Sales by Type (2021-2026)
  7.3 Europe S-Amlodipine Sales by Application (2021-2026)
  7.4 Germany
  7.5 France
  7.6 UK
  7.7 Italy
  7.8 Russia

8 MIDDLE EAST & AFRICA

  8.1 Middle East & Africa S-Amlodipine by Country
  8.1.1 Middle East & Africa S-Amlodipine Sales by Country (2021-2026)
  8.1.2 Middle East & Africa S-Amlodipine Revenue by Country (2021-2026)
  8.2 Middle East & Africa S-Amlodipine Sales by Type (2021-2026)
  8.3 Middle East & Africa S-Amlodipine Sales by Application (2021-2026)
  8.4 Egypt
  8.5 South Africa
  8.6 Israel
  8.7 Turkey
  8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

  9.1 Market Drivers & Growth Opportunities
  9.2 Market Challenges & Risks
  9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

  10.1 Raw Material and Suppliers
  10.2 Manufacturing Cost Structure Analysis of S-Amlodipine
  10.3 Manufacturing Process Analysis of S-Amlodipine
  10.4 Industry Chain Structure of S-Amlodipine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

  11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
  11.2 S-Amlodipine Distributors
  11.3 S-Amlodipine Customer

12 WORLD FORECAST REVIEW FOR S-AMLODIPINE BY GEOGRAPHIC REGION

  12.1 Global S-Amlodipine Market Size Forecast by Region
  12.1.1 Global S-Amlodipine Forecast by Region (2027-2032)
  12.1.2 Global S-Amlodipine Annual Revenue Forecast by Region (2027-2032)
  12.2 Americas Forecast by Country (2027-2032)
  12.3 APAC Forecast by Region (2027-2032)
  12.4 Europe Forecast by Country (2027-2032)
  12.5 Middle East & Africa Forecast by Country (2027-2032)
  12.6 Global S-Amlodipine Forecast by Type (2027-2032)
  12.7 Global S-Amlodipine Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

  13.1 Aristo Pharmaceuticals Pvt Ltd
  13.1.1 Aristo Pharmaceuticals Pvt Ltd Company Information
  13.1.2 Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Product Portfolios and Specifications
  13.1.3 Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Aristo Pharmaceuticals Pvt Ltd Main Business Overview
  13.1.5 Aristo Pharmaceuticals Pvt Ltd Latest Developments
  13.2 Novartis
  13.2.1 Novartis Company Information
  13.2.2 Novartis S-Amlodipine Product Portfolios and Specifications
  13.2.3 Novartis S-Amlodipine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Novartis Main Business Overview
  13.2.5 Novartis Latest Developments
  13.3 Pfizer
  13.3.1 Pfizer Company Information
  13.3.2 Pfizer S-Amlodipine Product Portfolios and Specifications
  13.3.3 Pfizer S-Amlodipine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Pfizer Main Business Overview
  13.3.5 Pfizer Latest Developments
  13.4 Lek
  13.4.1 Lek Company Information
  13.4.2 Lek S-Amlodipine Product Portfolios and Specifications
  13.4.3 Lek S-Amlodipine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Lek Main Business Overview
  13.4.5 Lek Latest Developments
  13.5 TEVA
  13.5.1 TEVA Company Information
  13.5.2 TEVA S-Amlodipine Product Portfolios and Specifications
  13.5.3 TEVA S-Amlodipine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 TEVA Main Business Overview
  13.5.5 TEVA Latest Developments
  13.6 Macleods Pharmaceuticals
  13.6.1 Macleods Pharmaceuticals Company Information
  13.6.2 Macleods Pharmaceuticals S-Amlodipine Product Portfolios and Specifications
  13.6.3 Macleods Pharmaceuticals S-Amlodipine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Macleods Pharmaceuticals Main Business Overview
  13.6.5 Macleods Pharmaceuticals Latest Developments
  13.7 Caraco Pharmaceutical
  13.7.1 Caraco Pharmaceutical Company Information
  13.7.2 Caraco Pharmaceutical S-Amlodipine Product Portfolios and Specifications
  13.7.3 Caraco Pharmaceutical S-Amlodipine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Caraco Pharmaceutical Main Business Overview
  13.7.5 Caraco Pharmaceutical Latest Developments
  13.8 Sanis Health
  13.8.1 Sanis Health Company Information
  13.8.2 Sanis Health S-Amlodipine Product Portfolios and Specifications
  13.8.3 Sanis Health S-Amlodipine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Sanis Health Main Business Overview
  13.8.5 Sanis Health Latest Developments
  13.9 Jamp Pharma
  13.9.1 Jamp Pharma Company Information
  13.9.2 Jamp Pharma S-Amlodipine Product Portfolios and Specifications
  13.9.3 Jamp Pharma S-Amlodipine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Jamp Pharma Main Business Overview
  13.9.5 Jamp Pharma Latest Developments
  13.10 Accel Pharma
  13.10.1 Accel Pharma Company Information
  13.10.2 Accel Pharma S-Amlodipine Product Portfolios and Specifications
  13.10.3 Accel Pharma S-Amlodipine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Accel Pharma Main Business Overview
  13.10.5 Accel Pharma Latest Developments
  13.11 Jubilant Generics
  13.11.1 Jubilant Generics Company Information
  13.11.2 Jubilant Generics S-Amlodipine Product Portfolios and Specifications
  13.11.3 Jubilant Generics S-Amlodipine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 Jubilant Generics Main Business Overview
  13.11.5 Jubilant Generics Latest Developments
  13.12 Angita Pharma
  13.12.1 Angita Pharma Company Information
  13.12.2 Angita Pharma S-Amlodipine Product Portfolios and Specifications
  13.12.3 Angita Pharma S-Amlodipine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 Angita Pharma Main Business Overview
  13.12.5 Angita Pharma Latest Developments
  13.13 Florida DOH Central Pharmacy
  13.13.1 Florida DOH Central Pharmacy Company Information
  13.13.2 Florida DOH Central Pharmacy S-Amlodipine Product Portfolios and Specifications
  13.13.3 Florida DOH Central Pharmacy S-Amlodipine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.13.4 Florida DOH Central Pharmacy Main Business Overview
  13.13.5 Florida DOH Central Pharmacy Latest Developments
  13.14 Chengdu Di'ao Pharmaceutical Group Co., Ltd.
  13.14.1 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Company Information
  13.14.2 Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Product Portfolios and Specifications
  13.14.3 Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.14.4 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Main Business Overview
  13.14.5 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Latest Developments
  13.15 Yangzijiang Pharmaceutical
  13.15.1 Yangzijiang Pharmaceutical Company Information
  13.15.2 Yangzijiang Pharmaceutical S-Amlodipine Product Portfolios and Specifications
  13.15.3 Yangzijiang Pharmaceutical S-Amlodipine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.15.4 Yangzijiang Pharmaceutical Main Business Overview
  13.15.5 Yangzijiang Pharmaceutical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. S-Amlodipine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. S-Amlodipine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Amlodipine Besylate Tablets
Table 4. Major Players of Amlodipine Mesylate Tablets
Table 5. Major Players of Amlodipine Maleate Tablets
Table 6. Global S-Amlodipine Sales by Type (2021-2026) & (K Units)
Table 7. Global S-Amlodipine Sales Market Share by Type (2021-2026)
Table 8. Global S-Amlodipine Revenue by Type (2021-2026) & ($ million)
Table 9. Global S-Amlodipine Revenue Market Share by Type (2021-2026)
Table 10. Global S-Amlodipine Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global S-Amlodipine Sale by Application (2021-2026) & (K Units)
Table 12. Global S-Amlodipine Sale Market Share by Application (2021-2026)
Table 13. Global S-Amlodipine Revenue by Application (2021-2026) & ($ million)
Table 14. Global S-Amlodipine Revenue Market Share by Application (2021-2026)
Table 15. Global S-Amlodipine Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global S-Amlodipine Sales by Company (2021-2026) & (K Units)
Table 17. Global S-Amlodipine Sales Market Share by Company (2021-2026)
Table 18. Global S-Amlodipine Revenue by Company (2021-2026) & ($ millions)
Table 19. Global S-Amlodipine Revenue Market Share by Company (2021-2026)
Table 20. Global S-Amlodipine Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers S-Amlodipine Producing Area Distribution and Sales Area
Table 22. Players S-Amlodipine Products Offered
Table 23. S-Amlodipine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global S-Amlodipine Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global S-Amlodipine Sales Market Share Geographic Region (2021-2026)
Table 28. Global S-Amlodipine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global S-Amlodipine Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global S-Amlodipine Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global S-Amlodipine Sales Market Share by Country/Region (2021-2026)
Table 32. Global S-Amlodipine Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global S-Amlodipine Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas S-Amlodipine Sales by Country (2021-2026) & (K Units)
Table 35. Americas S-Amlodipine Sales Market Share by Country (2021-2026)
Table 36. Americas S-Amlodipine Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas S-Amlodipine Sales by Type (2021-2026) & (K Units)
Table 38. Americas S-Amlodipine Sales by Application (2021-2026) & (K Units)
Table 39. APAC S-Amlodipine Sales by Region (2021-2026) & (K Units)
Table 40. APAC S-Amlodipine Sales Market Share by Region (2021-2026)
Table 41. APAC S-Amlodipine Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC S-Amlodipine Sales by Type (2021-2026) & (K Units)
Table 43. APAC S-Amlodipine Sales by Application (2021-2026) & (K Units)
Table 44. Europe S-Amlodipine Sales by Country (2021-2026) & (K Units)
Table 45. Europe S-Amlodipine Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe S-Amlodipine Sales by Type (2021-2026) & (K Units)
Table 47. Europe S-Amlodipine Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa S-Amlodipine Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa S-Amlodipine Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa S-Amlodipine Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa S-Amlodipine Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of S-Amlodipine
Table 53. Key Market Challenges & Risks of S-Amlodipine
Table 54. Key Industry Trends of S-Amlodipine
Table 55. S-Amlodipine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. S-Amlodipine Distributors List
Table 58. S-Amlodipine Customer List
Table 59. Global S-Amlodipine Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global S-Amlodipine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas S-Amlodipine Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas S-Amlodipine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC S-Amlodipine Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC S-Amlodipine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe S-Amlodipine Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe S-Amlodipine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa S-Amlodipine Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa S-Amlodipine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global S-Amlodipine Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global S-Amlodipine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global S-Amlodipine Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global S-Amlodipine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Aristo Pharmaceuticals Pvt Ltd Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 74. Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Product Portfolios and Specifications
Table 75. Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Aristo Pharmaceuticals Pvt Ltd Main Business
Table 77. Aristo Pharmaceuticals Pvt Ltd Latest Developments
Table 78. Novartis Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 79. Novartis S-Amlodipine Product Portfolios and Specifications
Table 80. Novartis S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Novartis Main Business
Table 82. Novartis Latest Developments
Table 83. Pfizer Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 84. Pfizer S-Amlodipine Product Portfolios and Specifications
Table 85. Pfizer S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Pfizer Main Business
Table 87. Pfizer Latest Developments
Table 88. Lek Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 89. Lek S-Amlodipine Product Portfolios and Specifications
Table 90. Lek S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Lek Main Business
Table 92. Lek Latest Developments
Table 93. TEVA Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 94. TEVA S-Amlodipine Product Portfolios and Specifications
Table 95. TEVA S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. TEVA Main Business
Table 97. TEVA Latest Developments
Table 98. Macleods Pharmaceuticals Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 99. Macleods Pharmaceuticals S-Amlodipine Product Portfolios and Specifications
Table 100. Macleods Pharmaceuticals S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Macleods Pharmaceuticals Main Business
Table 102. Macleods Pharmaceuticals Latest Developments
Table 103. Caraco Pharmaceutical Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 104. Caraco Pharmaceutical S-Amlodipine Product Portfolios and Specifications
Table 105. Caraco Pharmaceutical S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Caraco Pharmaceutical Main Business
Table 107. Caraco Pharmaceutical Latest Developments
Table 108. Sanis Health Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 109. Sanis Health S-Amlodipine Product Portfolios and Specifications
Table 110. Sanis Health S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Sanis Health Main Business
Table 112. Sanis Health Latest Developments
Table 113. Jamp Pharma Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 114. Jamp Pharma S-Amlodipine Product Portfolios and Specifications
Table 115. Jamp Pharma S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Jamp Pharma Main Business
Table 117. Jamp Pharma Latest Developments
Table 118. Accel Pharma Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 119. Accel Pharma S-Amlodipine Product Portfolios and Specifications
Table 120. Accel Pharma S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Accel Pharma Main Business
Table 122. Accel Pharma Latest Developments
Table 123. Jubilant Generics Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 124. Jubilant Generics S-Amlodipine Product Portfolios and Specifications
Table 125. Jubilant Generics S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Jubilant Generics Main Business
Table 127. Jubilant Generics Latest Developments
Table 128. Angita Pharma Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 129. Angita Pharma S-Amlodipine Product Portfolios and Specifications
Table 130. Angita Pharma S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Angita Pharma Main Business
Table 132. Angita Pharma Latest Developments
Table 133. Florida DOH Central Pharmacy Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 134. Florida DOH Central Pharmacy S-Amlodipine Product Portfolios and Specifications
Table 135. Florida DOH Central Pharmacy S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Florida DOH Central Pharmacy Main Business
Table 137. Florida DOH Central Pharmacy Latest Developments
Table 138. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 139. Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Product Portfolios and Specifications
Table 140. Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Main Business
Table 142. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Latest Developments
Table 143. Yangzijiang Pharmaceutical Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 144. Yangzijiang Pharmaceutical S-Amlodipine Product Portfolios and Specifications
Table 145. Yangzijiang Pharmaceutical S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. Yangzijiang Pharmaceutical Main Business
Table 147. Yangzijiang Pharmaceutical Latest Developments

LIST OF FIGURES

Figure 1. Picture of S-Amlodipine
Figure 2. S-Amlodipine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global S-Amlodipine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global S-Amlodipine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. S-Amlodipine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. S-Amlodipine Sales Market Share by Country/Region (2025)
Figure 10. S-Amlodipine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Amlodipine Besylate Tablets
Figure 12. Product Picture of Amlodipine Mesylate Tablets
Figure 13. Product Picture of Amlodipine Maleate Tablets
Figure 14. Global S-Amlodipine Sales Market Share by Type in 2026
Figure 15. Global S-Amlodipine Revenue Market Share by Type (2021-2026)
Figure 16. S-Amlodipine Consumed in Hypertension
Figure 17. Global S-Amlodipine Market: Hypertension (2021-2026) & (K Units)
Figure 18. S-Amlodipine Consumed in Angina pectoris
Figure 19. Global S-Amlodipine Market: Angina pectoris (2021-2026) & (K Units)
Figure 20. Global S-Amlodipine Sale Market Share by Application (2025)
Figure 21. Global S-Amlodipine Revenue Market Share by Application in 2026
Figure 22. S-Amlodipine Sales by Company in 2026 (K Units)
Figure 23. Global S-Amlodipine Sales Market Share by Company in 2026
Figure 24. S-Amlodipine Revenue by Company in 2026 ($ millions)
Figure 25. Global S-Amlodipine Revenue Market Share by Company in 2026
Figure 26. Global S-Amlodipine Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global S-Amlodipine Revenue Market Share by Geographic Region in 2026
Figure 28. Americas S-Amlodipine Sales 2021-2026 (K Units)
Figure 29. Americas S-Amlodipine Revenue 2021-2026 ($ millions)
Figure 30. APAC S-Amlodipine Sales 2021-2026 (K Units)
Figure 31. APAC S-Amlodipine Revenue 2021-2026 ($ millions)
Figure 32. Europe S-Amlodipine Sales 2021-2026 (K Units)
Figure 33. Europe S-Amlodipine Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa S-Amlodipine Sales 2021-2026 (K Units)
Figure 35. Middle East & Africa S-Amlodipine Revenue 2021-2026 ($ millions)
Figure 36. Americas S-Amlodipine Sales Market Share by Country in 2026
Figure 37. Americas S-Amlodipine Revenue Market Share by Country (2021-2026)
Figure 38. Americas S-Amlodipine Sales Market Share by Type (2021-2026)
Figure 39. Americas S-Amlodipine Sales Market Share by Application (2021-2026)
Figure 40. United States S-Amlodipine Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada S-Amlodipine Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico S-Amlodipine Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil S-Amlodipine Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC S-Amlodipine Sales Market Share by Region in 2026
Figure 45. APAC S-Amlodipine Revenue Market Share by Region (2021-2026)
Figure 46. APAC S-Amlodipine Sales Market Share by Type (2021-2026)
Figure 47. APAC S-Amlodipine Sales Market Share by Application (2021-2026)
Figure 48. China S-Amlodipine Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan S-Amlodipine Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea S-Amlodipine Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia S-Amlodipine Revenue Growth 2021-2026 ($ millions)
Figure 52. India S-Amlodipine Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia S-Amlodipine Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan S-Amlodipine Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe S-Amlodipine Sales Market Share by Country in 2026
Figure 56. Europe S-Amlodipine Revenue Market Share by Country (2021-2026)
Figure 57. Europe S-Amlodipine Sales Market Share by Type (2021-2026)
Figure 58. Europe S-Amlodipine Sales Market Share by Application (2021-2026)
Figure 59. Germany S-Amlodipine Revenue Growth 2021-2026 ($ millions)
Figure 60. France S-Amlodipine Revenue Growth 2021-2026 ($ millions)
Figure 61. UK S-Amlodipine Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy S-Amlodipine Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia S-Amlodipine Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa S-Amlodipine Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa S-Amlodipine Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa S-Amlodipine Sales Market Share by Application (2021-2026)
Figure 67. Egypt S-Amlodipine Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa S-Amlodipine Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel S-Amlodipine Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey S-Amlodipine Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries S-Amlodipine Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of S-Amlodipine in 2026
Figure 73. Manufacturing Process Analysis of S-Amlodipine
Figure 74. Industry Chain Structure of S-Amlodipine
Figure 75. Channels of Distribution
Figure 76. Global S-Amlodipine Sales Market Forecast by Region (2027-2032)
Figure 77. Global S-Amlodipine Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global S-Amlodipine Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global S-Amlodipine Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global S-Amlodipine Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global S-Amlodipine Revenue Market Share Forecast by Application (2027-2032)


More Publications